| 出品公司: | ATCC |
|---|---|
| 菌种名称: | ATCC51435,ATCC 51435 |
| 菌种又名: | B2F1 |
| 菌株类型: | 热液古柏氏菌Guyparkeria hydrothermalis |
| 存储人: | AD O'Brien |
| 分离来源: | 临床标本 |
| 产品目录号: | 51435 |
| 培养基: | ATCC培养基1065:LB琼脂/肉汤，米勒 |
| 生长条件: | 37 ℃ |
| 生物安全等级: | 1 |
| 模式菌株: | 否 |
| 应用: |
科研，生产，主要用于肠道疾病研究
传染病研究
产志贺样毒素II
肠道研究
|
| 菌株特点: |
ATCC51435 热液古柏氏菌Guyparkeria hydrothermalis |
| 参考文献: |
Lindgren SW, et al. The specific activities of Shiga-like toxin type II (SLT-II) and SLT-II-related toxins of enterohemorrhagic Escherichia coli differ when measured by Vero cell cytotoxicity but not by mouse lethality. Infect. Immun. 62: 623-631, 1994. PubMed: 8300218
Lindgren SW, et al. Virulence of enterohemorrhagic Escherichia coli O91:H21 clinical isolates in an orally infected mouse model. Infect. Immun. 61: 3832-3842, 1993. PubMed: 8359904
Ito H, et al. Cloning and nucleotide sequencing of Vero toxin 2 variant genes from Escherichia coli O91:H21 isolated from a patient with the hemolytic uremic syndrome. Microb. Pathog. 8: 47-60, 1990. PubMed: 2185397
Oku Y, et al. Purification and some properties of a Vero toxin from a human strain of Escherichia coli that is immunologically related to Shiga-like toxin II (VT2). Microb. Pathog. 6: 113-122, 1989. PubMed: 2654533
patient with hemolytic uremic syndrome, Toronto
|
买家导航
